Specifically, Gao et al. [21] showed that reduced NCOA5 expression is associated with a fraction of human hepatocellular carcinoma cancers (HCC) and argued that susceptibility to both glucose intolerance and HCC increases with NCOA5 deficiency. This evidence concerns the gene NCOA5 and hepatocellular carcinoma.